Thank you for your interest in participating in the Screening for Cerebral Visual Impairment (CVI) in Angelman Syndrome study at Boston Children's Hospital! 

This study aims to better understand the prevalence of CVI in individuals with Angelman syndrome. CVI affects how the brain processes visual information and has been linked to epilepsy and other neurodevelopmental disorders.

We would greatly appreciate your participation. Your involvement would include a one-time remote visit.

What to expect:

  • Copy of genetic testing: You will be asked to provide the study team with your child's genetic testing results that confirm a diagnosis of Angelman syndrome.
    • If your child is already participating in the Angelman Syndrome Natural History Study, we likely have these results on file.
  • Informed consent: You will review and sign the informed consent form before the virtual study visit.
  • 30-minute virtual visit: The study visit will be conducted remotely via phone or Zoom. During this time, you (the caregiver of an individual with Angelman syndrome) will answer questions about your child's visual health and behaviors.

After the study visit:

  • You will receive your child's CVI screening results following the visit.
  • If your child screens positive for CVI, we will provide educational resources and support materials.

If you have any questions about this study, please feel free to reach out to Emma Bauschard at emmabauschard@childrens.harvard.edu.

Loading... Loading...
You have selected an option that triggers this survey to end right now.
To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.